CORC

浏览/检索结果: 共3条,第1-3条 帮助

限定条件                        
已选(0)清除 条数/页:   排序方式:
Efficacy, safety, and pharmacokinetics of the anti-programmed cell death receptor-1 (PD-1) monoclonal antibody, tislelizumab (BGB-A317) in a phase 2, open-label, multicenter study to investigate in patients with unresectable hepatocellular carcinoma - Trial in progress 会议论文
作者:  Ren, Z.;  Assenat, E.;  Cubillo, A.;  Pluntke, S.;  Rimassa, L.
收藏  |  浏览/下载:11/0  |  提交时间:2019/12/05
Intestinal radiation plays a pivotal role in CTLA-4 Ab induced an autoimmune enteritis mouse model 会议论文
作者:  Wan, J.;  Cheng, J.;  Fuller, J.;  Feldman, R.;  Zhang, Z.
收藏  |  浏览/下载:10/0  |  提交时间:2019/12/05
Phase III trial of chidamide, a subtype-selective histone deacetylase (HDAC) inhibitor, in combination with exemestane in patients with hormone receptor-positive advanced breast cancer 会议论文
作者:  Jiang, Z.;  Li, W.;  Hu, X.;  Zhang, Q.;  Sun, T.
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace